Thrombus formation induced by antibodies to β2-glycoprotein I is complement dependent and requires a priming factor

Fabio Fischetti, Paolo Durigutto, Valentina Pellis, +8

Blood

C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation

Roberta Bulla, Claudio Tripodo, Damiano Rami, +7

Nature Communications

A non–complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome

Chiara Agostinis, Paolo Durigutto, Daniele Sblattero, +8

Blood

Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo

Giorgio Zauli, Federica Corallini, Fleur Bossi, +5

Blood

In vivo distribution of β2 glycoprotein I under various pathophysiologic conditions

Chiara Agostinis, Stefania Biffi, Chiara Garrovo, +8

Blood

The Neutrophil-Activating Protein of <i>Helicobacter pylori</i> Crosses Endothelia to Promote Neutrophil Adhesion In Vivo

Alessandra Polenghi, Fleur Bossi, Fabio Fischetti, +7

The Journal of Immunology

Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency

Fleur Bossi, Fabio Fischetti, D. Regoli, +7

Journal of Allergy and Clinical Immunology

Translational MedicineVascular DiseaseAngiogenesisNovel Pathogenic MechanismC1 Inhibitor Deficiency +10

Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice

Paolo Macor, Erika Secco, Nelly Mezzaroba, +12

Leukemia

Tumor ImmunologyCancer ImmunosurveillanceImmunologyTherapeutic VaccineComplement Regulators +10

Multiple-Organ Complement Deposition on Vascular Endothelium in COVID-19 Patients

Paolo Macor, Paolo Durigutto, Alessandro Mangogna, +7

Biomedicines

VasculitisLaboratory ImmunologyHumoral ResponseImmunologyPathology +14

Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis

Federico Colombo, Paolo Durigutto, Luca De Maso, +19

Journal of Autoimmunity

NanoparticlesRheumatologyNanomedicineDrug TargetingEngineering +8